Interestingly, both down-regulation of CD146 cell-surface expression using siRNA and antibody-mediated blockade of CD146 increase this apoptosis.
Our results identify Galectin-1 as a novel ligand for CD146 and this interaction protects, in vitro, endothelial cells against apoptosis induced by Galectin-1.